Scientists and doctors promote debate on cannabinoid and psychedelic therapies

Next month, on May 23, 24, and 25, 2024, the Expo Center Norte will host the 3rd Brazilian Congress on Medicinal Cannabis. With a comprehensive program that includes over 100 speakers and the expectation of gathering 1,200 attendees, the event promises to be a milestone in the Brazilian health landscape.

One of the main highlights of the congress will be the module dedicated to the endocannabinoid system, its interaction with physiology, pharmacology, and clinical applications, as well as discussions on psychedelic treatments and case study analyses.

Buy your ticket with a 15% discount here.

Here are some confirmed speakers:

Renata Monteiro: Pharmacist and Researcher, specialist in medicinal cannabis, whose work at Orthofarma and the Jurema Institute provides valuable insights into the therapeutic use of cannabis.

Fabrício Pamplona: Neuroscientist with extensive experience in cannabinoid pharmacology, offering fundamental insights into the effects and applications of these substances.

Ana Hounie: Doctor and representative of Brazil on the Advisory Council of APMC, whose expertise in psychiatry and prescription of medicinal cannabis since 2015 adds a crucial dimension to the debate.

Flavio Geraldes Alves: Doctor with a career dedicated to cannabis research and ASD (Autism Spectrum Disorder), providing a comprehensive view of clinical and therapeutic aspects.

Jackeline Barbosa: Doctor with extensive training in neurology and phytotherapy, whose role in coordinating departments and medical associations reinforces the importance of integrating cannabis into clinical practice.

Lauro Pontes: Psychologist and cannabis researcher since 2014, whose clinical and academic experience brings a multidisciplinary and enriching approach to the debate.

Marcus Zanetti: Psychiatrist and Doctor of Sciences, whose contribution to understanding the psychotherapeutic effects of cannabis is of utmost importance.
Pedro Pierro: Functional Neurosurgeon and pioneer in the prescription of Medicinal Cannabis in Brazil, whose knowledge in psychiatric surgery and pain treatment offers a unique perspective on the use of cannabis as therapy.

These specialists, among others, promise to enrich the debate and contribute to the advancement of knowledge about medicinal cannabis in Brazil. Whether through their research, clinical experiences, or academic work, each speaker will bring an important piece to the puzzle of therapeutic cannabis use.